Investigational drug helps opioid-induced constipation

10/25/2012 | MedPage Today

The investigational opioid antagonist drug TD-1211 eased opioid-induced constipation for chronic pain patients compared with a placebo, researchers told a gastroenterology conference. The effect lasted for at least three weeks and the drug did not interfere with the pain medication.

View Full Article in:

MedPage Today

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
European Sales Manager
SentreHEART, Inc.
Germany, Benelux, UK
REG AFFAIRS PROJ MGR - 1400000A7F
Abbott
San Jose, CA
SPECIALIST II SYSTEMS INTEGRATION - 140000033P
Abbott
Dallas, TX
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD